Jakafi 20 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DR26FCYU8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,677
Award facts
- Contract value 100% obligated
- $24,676.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 20 mg tablets (60-count units) valued at $24,676.82. The delivery order, awarded on November 3, 2025, with an ultimate completion date of November 4, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical support to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with its IDC contract (designated SPE2DR) featuring a $499,999,999 ceiling value and extending through December 31, 2036. The contract structure includes a 30-month base period with three 30-month option periods, positioning the contractor to supply a broad range of pharmaceutical products including branded and generic prescription medications, biologics, vaccines, and medical consumables to support recurring medical supply needs across the global military healthcare system. The company's demonstrated performance on numerous delivery orders reflects its capability to fulfill the diverse and specialized pharmaceutical requirements essential to Department of Defense operations.
Quick answers
Who was awarded contract SPE2DR26FCYU8?
SPE2DR26FCYU8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DR26FCYU8 worth?
The government has obligated $24,677 on SPE2DR26FCYU8.
Is contract SPE2DR26FCYU8 an order under another contract?
Yes. SPE2DR26FCYU8 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.
Was contract SPE2DR26FCYU8 competed?
The extent of competition for SPE2DR26FCYU8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award